Schizophreniform Disorders Clinical Trial
Official title:
The Effectiveness of a Mindfulness Psychoeducation Program on Emotional Regulation for People With Schizophrenia: A Pilot Randomized Control Trial
The study is the first pilot randomised controlled trial (RCT) to explore the feasibility and efficacy of Mindfulness-based psychoeducation in emotion regulation and related depressive and anxiety symptoms in people with schizophrenia.
There is increasing evidence to demonstrate the safety and effectiveness of mindfulness-based
psychoeducation programme (MBPP) for Chinese people with schizophrenia. A single-blind,
multi-site, pragmatic randomised controlled trial conducted in Hong Kong, mainland China, and
Taiwan with 300 participants consistently demonstrated significant improvement in regard to
insight of illness, functioning, mental state and the length of re-hospitalisations when
compared with conventional psychoeducation and Treatment As Usual (TAU) groups (Chien, 2017).
The study hypothesises that:
1. Participants receiving MBPP will decrease their use of rumination and expressive
suppression, and increase the use of cognitive reappraisal compared to a control group
after completion of the intervention.
2. Participants receiving MBPP attain a reduction in depressive/anxiety symptoms compared
to a control group after completion of the intervention.
3. These effects are expected to be maintained through 3-month follow up with regular
self-practice.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
| Completed |
NCT00419146 -
Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05974527 -
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
|
Phase 4 | |
| Recruiting |
NCT04113993 -
Bazedoxifene -Treatment for Women With Schizophrenia
|
Phase 4 | |
| Completed |
NCT03067311 -
Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy
|
N/A | |
| Recruiting |
NCT06041646 -
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
|
Phase 4 | |
| Completed |
NCT04418011 -
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders
|
N/A | |
| Active, not recruiting |
NCT05658510 -
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
|
Phase 3 | |
| Terminated |
NCT00515489 -
Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients
|
N/A | |
| Recruiting |
NCT05877716 -
EPI-MINN: Targeting Cognition and Motivation - National
|
N/A | |
| Completed |
NCT03079024 -
Minnesota Community-Based Cognitive Training in Early Psychosis
|
N/A | |
| Completed |
NCT03559426 -
Research Into Antipsychotic Discontinuation and Reduction Trial
|
Phase 4 | |
| Recruiting |
NCT04497857 -
Academic-Community EPINET (AC-EPINET)
|
N/A | |
| Recruiting |
NCT05109065 -
Peripheral Immune System in Individuals With Schizophrenia
|
||
| Completed |
NCT03187769 -
Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder
|
Phase 3 | |
| Completed |
NCT01082588 -
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
|
Phase 4 | |
| Recruiting |
NCT05538832 -
Remote State Representation in Early Psychosis
|
Early Phase 1 | |
| Recruiting |
NCT06002958 -
Horyzons: Implementation and Integration in Clinical Practice
|
N/A | |
| Recruiting |
NCT03919760 -
Early Psychosis Intervention - Spreading Evidence-based Treatment
|
||
| Completed |
NCT04268303 -
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
|
Phase 3 |